Scarica l'app Stockscreener
52.48
1.00%
-0.53
Dopo l'orario di chiusura:
52.48
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$53.01
Aprire:
$52.84
Volume 24 ore:
2.10M
Relative Volume:
0.84
Capitalizzazione di mercato:
$7.97B
Reddito:
$3.44B
Utile/perdita netta:
$75.20M
Rapporto P/E:
100.17
EPS:
0.5239
Flusso di cassa netto:
$49.30M
1 W Prestazione:
+11.40%
1M Prestazione:
+14.09%
6M Prestazione:
+23.89%
1 anno Prestazione:
-13.90%
Intervallo 1D:
$51.70
$53.09
Intervallo di 1 settimana:
$46.85
$53.47
Portata 52W:
$28.53
$64.64
Bruker Corp Stock (BRKR) Company Profile
Nome
Bruker Corp
Settore
Industria
Telefono
978663-3660
Indirizzo
40 MANNING RD, BILLERICA, MA
Confronta BRKR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
52.48 | 8.05B | 3.44B | 75.20M | 49.30M | 0.5239 |
|
ABT
Abbott Laboratories
|
126.18 | 220.91B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.38 | 146.24B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.21 | 140.64B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
98.69 | 127.91B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.58 | 49.23B | 5.88B | 1.34B | 799.60M | 2.3489 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-10 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-12-09 | Iniziato | Goldman | Sell |
| 2025-11-20 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-05-22 | Downgrade | Citigroup | Buy → Neutral |
| 2024-12-19 | Iniziato | Guggenheim | Buy |
| 2024-12-10 | Iniziato | UBS | Neutral |
| 2024-12-05 | Aggiornamento | Goldman | Sell → Neutral |
| 2024-10-15 | Iniziato | Barclays | Overweight |
| 2024-09-30 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-02-14 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-12-19 | Iniziato | Wells Fargo | Equal Weight |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2022-10-21 | Iniziato | UBS | Buy |
| 2022-08-22 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-10-15 | Ripresa | Cowen | Market Perform |
| 2021-06-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2021-02-05 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-12-02 | Iniziato | Goldman | Sell |
| 2020-11-16 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2020-05-01 | Downgrade | Cleveland Research | Buy → Neutral |
| 2020-04-02 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| 2020-04-01 | Downgrade | Needham | Strong Buy → Hold |
| 2020-03-26 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Hold |
| 2019-09-26 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | Aggiornamento | Goldman | Sell → Neutral |
| 2019-06-24 | Reiterato | Needham | Strong Buy |
| 2019-06-21 | Reiterato | BofA/Merrill | Neutral |
| 2019-05-30 | Iniziato | Wolfe Research | Peer Perform |
| 2019-05-06 | Reiterato | Needham | Strong Buy |
| 2019-05-03 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-03 | Aggiornamento | UBS | Sell → Neutral |
| 2019-04-12 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2019-02-12 | Reiterato | BTIG Research | Buy |
| 2019-01-03 | Iniziato | Needham | Strong Buy |
Mostra tutto
Bruker Corp Borsa (BRKR) Ultime notizie
Will Bruker Corporation (BKD) stock outperform foreign stocksJuly 2025 Institutional & Pattern Based Trade Signal System - ulpravda.ru
Is Bruker Corporation stock a defensive play in 2025Market Performance Summary & Risk Controlled Stock Pick Alerts - ulpravda.ru
Bruker acquires remaining 60% stake in TOFWERK for full ownership By Investing.com - Investing.com Canada
Bruker deal expands TOF tech for cleaner air and semiconductor cleanrooms - Stock Titan
How to listen in as Bruker joins J.P. Morgan's big health event - Stock Titan
Is Bruker (BRKR) Pricing Reflecting Its Life Sciences Role And Mixed Valuation Signals? - Yahoo Finance
Bruker Meets 80-Plus Relative Strength Rating Benchmark - Investor's Business Daily
Bruker (BRKR) Is Up 7.9% After Winning €35 Million ELI-NP Order In Romania - simplywall.st
Guggenheim Maintains Bruker Corp(BRKR.US) With Buy Rating, Announces Target Price $53 - 富途牛牛
Why Bruker (BRKR) Stock Is Up Today - Finviz
AbCellera settles patent litigation with Bruker over microfluidic device tech - MSN
Bruker (BRKR) Receives Analyst Rating and Price Target Upgrade f - GuruFocus
Winners And Losers Of Q3: Bruker (NASDAQ:BRKR) Vs The Rest Of The Research Tools & Consumables Stocks - Finviz
Benchtop X-Ray Diffraction Platform | Bruker AXS GmbH | Jul 2023 - Photonics Spectra
Insider Stock Buying Reaches US$1.14m On Bruker - 富途牛牛
Bruker secures $10M in federally funded NMR orders from NYSBC, Delaware, and Northwestern - MSN
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A (BRKRP) Competitors - Meyka
Why a $30 Million Bruker Stock Trim Matters Amid an 18% Slide - AOL.com
Should You Continue to Hold BRKR Stock in Your Portfolio? - Finviz
Bruker (BRKR) Is Up 6.8% After Settling AbCellera Dispute And Securing Major ELI-NP Contracts - Yahoo Finance
Does Bruker’s 2025 Share Price Slide Present a Hidden Opportunity? - Yahoo Finance
3D Measuring Device | Bruker Alicona | May 2024 - Photonics Spectra
Bruker (BRKR) Valuation Check After €35m ELI-NP Contract Win Drives Fresh Growth Hopes - Yahoo Finance
Bruker Corporation $BRKR Shares Sold by Orion Porfolio Solutions LLC - MarketBeat
Bruker (MIL:1BRKR) EV-to-OCF : 73.37 (As of Dec. 20, 2025) - GuruFocus
Will AbCellera’s (ABCL) Bruker Patent Settlement and Royalties Shift Its Long-Term Revenue Narrative? - simplywall.st
Why Bruker Corporation stock appeals to dividend seekersMarket Trend Review & Weekly Watchlist for Consistent Profits - DonanımHaber
Will Bruker’s (BRKR) AbCellera Settlement and Beacon Royalties Deal Change Its Investment Narrative? - simplywall.st
Will Bruker Corporation stock continue upward momentumMarket Growth Summary & Real-Time Stock Movement Alerts - Улправда
Why Bruker Corporation stock is rated strong buy2025 Buyback Activity & Long-Term Safe Investment Plans - ulpravda.ru
Can Bruker Corporation stock maintain growth trajectoryWeekly Investment Report & Long Hold Capital Preservation Tips - ulpravda.ru
AbCellera stock jumps after settlement with Bruker in patent dispute - Investing.com
Bruker (BRKR) Agrees to $36M Settlement with AbCellera (ABCL) - GuruFocus
AbCellera settles patent dispute with Bruker for $36 million upfront - Investing.com
AbCellera and Bruker Reach Global Settlement of Patent Litigation - Yahoo Finance
Volume Summary: Will Bruker Corporation stock continue upward momentumProfit Target & High Return Stock Watch Alerts - ulpravda.ru
How Recent Analyst Shifts Are Reshaping The Bruker Investment Story - Yahoo Finance
YieldBoost Bruker From 0.4% To 11.2% Using Options - Nasdaq
A Quick Look at Today's Ratings for Bruker Corp(BRKR.US), With a Forecast Between $55 to $60 - 富途牛牛
Bruker Corporation $BRKR Shares Sold by Squarepoint Ops LLC - MarketBeat
Reassessing Bruker’s 2025 Valuation After Share Price Rebound And Life Sciences Expansion - simplywall.st
Bruker Is Maintained at Overweight by Barclays - 富途牛牛
Wells Fargo Raises Bruker (BRKR) Price Target to $55 | BRKR Stoc - GuruFocus
Wells Fargo Maintains Bruker Corp(BRKR.US) With Buy Rating, Raises Target Price to $55 - 富途牛牛
Bank of America Raises Bruker (NASDAQ:BRKR) Price Target to $60.00 - MarketBeat
Bruker Is Maintained at Buy by B of A Securities - 富途牛牛
Barclays Maintains Bruker Corp(BRKR.US) With Buy Rating, Raises Target Price to $55 - 富途牛牛
Bruker (BRKR): Reassessing Valuation After a Sharp Three-Month Share Price Rebound - simplywall.st
London Co. of Virginia Reduces Holdings in Bruker Corporation $BRKR - MarketBeat
Does Bruker (NASDAQ:BRKR) Have A Healthy Balance Sheet? - 富途牛牛
Goldman Sachs Initiates Sell Rating On Bruker Corporation (BRKR) - Insider Monkey
Bruker Corp Azioni (BRKR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.10%
0.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):